Does metformin usage improve survival in head and neck squamous cell carcinoma? A population-based study

BACKGROUND: We sought to expand upon preliminary data suggesting that metformin confers a survival benefit to patients with head and neck squamous cell carcinoma (HNSCC). METHODS: A large-scale retrospective cohort study of all patients in Ontario diagnosed with squamous cancer of the larynx, hypoph...

Descripción completa

Detalles Bibliográficos
Autores principales: Quimby, Alexandra E., Lebo, Nicole L., Griffiths, Rebecca, Hall, Stephen, Dimitroulakos, Jim, Johnson-Obaseki, Stephanie
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BioMed Central 2018
Materias:
Original Research Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6278022/
https://www.ncbi.nlm.nih.gov/pubmed/30514404
http://dx.doi.org/10.1186/s40463-018-0322-7

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6278022/
https://www.ncbi.nlm.nih.gov/pubmed/30514404
http://dx.doi.org/10.1186/s40463-018-0322-7

Ejemplares similares